Battaglia Yuri, Fiorini Fulvio, Gisonni Pietro, Imbriaco Massimo, Lentini Paolo, Zeiler Matthias, Russo Luigi, Prencipe Michele, Russo Domenico
Department of Medicine, University of Verona, 37129 Verona, Italy.
Nephrology and Dialysis Unit, Pederzoli Hospital, 37019 Peschiera del Garda, Italy.
Diagnostics (Basel). 2022 Jun 13;12(6):1454. doi: 10.3390/diagnostics12061454.
Although atherosclerotic renal artery stenosis (ARAS) is strictly associated with high cardiovascular risk and mortality, it often may remain unrecognized being clinically silent and frequently masked by co-morbidities especially in elderly patients with coexisting chronic kidney disease (CKD). The present observational study was conducted in elderly CKD-patients with atherosclerosis on other arterial beds. The aims were assessment of (1) ARAS prevalence; (2) best predictor(s) of ARAS, using duplex ultrasound; and (3) cardiovascular and renal outcomes at one-year follow-up. The cohort was represented by 607 consecutive in-patients. Inclusion criteria were age ≥65 years; CKD stages 2−5 not on dialysis; single or multiple atherosclerotic plaque on epiaortic vessels, abdominal aorta, aortic arch, coronary arteries, peripheral arteries that had been previously ascertained by one or more procedures. Duplex ultrasound was used to detect ARAS. Multiple regression analysis and ROS curve were performed to identify the predictors of ARAS. ARAS was found in 53 (44%) out of 120 patients who met the inclusion criteria. In univariate analysis, GFR (b = −0.021; p = 0.02); hemoglobin (b = −0.233; p = 0.02); BMI (b = 0.134; p = 0.036) and atherosclerosis of abdominal aorta and/or peripheral vessels (b = 1.025; p < 0.001) were associated with ARAS. In multivariable analysis, abdominal aorta and/or peripheral atherosclerosis was a significant (p = 0.002) predictor of ARAS. The area under the ROC curve was 0.655 (C.I. = 0.532−0.777; p = 0.019). ARAS is common in older CKD patients with extra-renal atherosclerosis, with the highest prevalence in those with aortic and peripheral atherosclerosis. ARAS may pass by unnoticed in everyday clinical practice.
尽管动脉粥样硬化性肾动脉狭窄(ARAS)与高心血管风险及死亡率密切相关,但它常常未被识别,因为其在临床上没有症状,且常被合并症掩盖,尤其是在同时患有慢性肾脏病(CKD)的老年患者中。本观察性研究针对其他动脉床存在动脉粥样硬化的老年CKD患者开展。目的是评估:(1)ARAS的患病率;(2)使用双功超声评估ARAS的最佳预测指标;(3)随访一年时的心血管和肾脏结局。该队列由607例连续住院患者组成。纳入标准为:年龄≥65岁;CKD 2 - 5期且未接受透析;经一种或多种检查确定在主动脉弓、腹主动脉、冠状动脉、外周动脉存在单发或多发动脉粥样硬化斑块。使用双功超声检测ARAS。进行多元回归分析和ROC曲线分析以确定ARAS的预测指标。在符合纳入标准的120例患者中,有53例(44%)发现有ARAS。单因素分析中,肾小球滤过率(b = -0.021;p = 0.02)、血红蛋白(b = -0.233;p = 0.02)、体重指数(b = 0.134;p = 0.036)以及腹主动脉和/或外周血管的动脉粥样硬化(b = 1.025;p < 0.001)与ARAS相关。多因素分析中,腹主动脉和/或外周动脉粥样硬化是ARAS的显著预测指标(p = 0.002)。ROC曲线下面积为0.655(C.I. = 0.532 - 0.777;p = 0.019)。ARAS在合并肾外动脉粥样硬化的老年CKD患者中很常见,在主动脉和外周动脉粥样硬化患者中患病率最高。在日常临床实践中,ARAS可能未被注意到。